Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Fosrenol receives approval in Sweden

March 26, 2004

NM-100061 produces positive results in early ejaculation study

March 25, 2004

Antares' topical oxybutynin product successfully completes phase I trial

March 19, 2004

Milestone achievements and patient treatment with Prolieve

March 16, 2004

GSK presents four related series of ALK5 inhibitors

March 16, 2004

Nippon Kayaku reports in vivo effects of NK-082411 on micturition

March 12, 2004

Patient, physician satisfaction with Levitra

March 12, 2004

Four new SOAR collaborations for KRX-101

March 12, 2004

Nippon Shinyaku and Seikagaku terminate NS-7201 license agreement

March 9, 2004

Technology transfer completed in Actelion/Merck renin alliance

March 8, 2004

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...